Its ability to enhance neurorepair and cognitive function makes Dihexa a promising tool for research into neurodegenerative conditions and cognitive performance support
The body attempts to overcome this limitation via the transsulfuration pathway in the liver, which converts the amino acid methionine into cysteine to ensure a steady supply for glutathione synthesis
It promotes the formation of blood vessels via a process known as angiogenesis, and upregulates vascular endothelial growth factor (VEGF), a protein that stimulates blood vessel growth
Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, ect
Injectable Protocol (Systemic + Gut) For users who want systemic delivery alongside gut-targeted action: Loading Phase (Weeks 1 to 4): BPC-157: 250 to 500 mcg per day, subcutaneous injection (abdomen) KPV: 200 to 500 mcg per day, subcutaneous injection (abdomen) Maintenance Phase (Weeks 5 to 8): BPC-157: 250 mcg per day KPV: 200 to 300 mcg per day Extended Stack Options For enhanced regenerative effect beyond gut health, some practitioners add: TB-500: 2 to 2.5 mg twice weekly adds systemic cell migration and tissue remodeling for broader recovery GHK-Cu: 1 to 2 mg per day subcutaneous adds collagen production support and wound healing acceleration Timing and Administration Notes For oral gut-focused use, some users dose BPC-157 in the morning and KPV in the evening to maintain continuous coverage throughout the day
Your provider can outline options and adjust as your needs change